Market-access agreements for anti-cancer drugs

Current Status and Trends in Performance-Based Risk-Sharing Arrangements Between Healthcare Payers and Medical Product Manufacturers

(2014) Josh J. Carlson et al.   Applied Health Economics and Health Policy

Performance-Based Risk-Sharing Arrangements—Good Practices for Design, Implementation, and Evaluation: Report of the ISPOR Good Practices for Performance-Based Risk-Sharing Arrangements Task Force

(2013) Louis P. Garrison et al.   VALUE IN HEALTH

Optional copayments on anti-cancer drugs

(2013) K. v. d. Vooren et al.   BMJ-British Medical Journal

Risk sharing agreements: What lessons from Italy?

(2011) Livio Garattini et al.   INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE

Risk sharing arrangements for pharmaceuticals: potential considerations and recommendations for European payers

(2010) Jakub Adamski et al.   BMC HEALTH SERVICES RESEARCH

Linking payment to health outcomes: A taxonomy and examination of performance-based reimbursement schemes between healthcare payers and manufacturers

(2010) Josh J. Carlson et al.   HEALTH POLICY

Funding the Unfundable

(2010) Tania Stafinski et al.   PHARMACOECONOMICS

Access with Evidence Development Schemes

(2010) Christopher J. McCabe et al.   PHARMACOECONOMICS